The global heart beat irregularity detection device market is forecasted to expand at 4.5% CAGR to reach a market valuation of US$ 20.7 Million by the end of 2033, up from US$ 12.8 Million that was recorded for 2022.
The market for heart beat irregularity detection devices is expected to be driven by rising incidences of cardiac arrhythmia that call for early identification for optimal care of heart patients.
| Attributes | Details |
|---|---|
| Heart Beat Irregularity Detection Device Market Size (2023) | US$ 13.4 Million |
| Forecasted Market Value (2033) | US$ 20.7 Million |
| Value CAGR (2023 to 2033) | 4.5% |
| Collective Value Share: Top 5 Countries (2022) | 55.4% |
| Key Market Players | Alive Cor, Applied Cardiac Systems, Biotronik, Biotricity, GE Healthcare, iRhythm Technologies, Koninklijke Philips N.V., Medtronic plc., Nihon Kohden Corporation, St. Jude Medical (Abbott Laboratories), Welch Allyn (Hillrom Services, Inc.), NUUBO Smart Solutions Technologies, SL, Spacelabs Healthcare, Inc. (OSI Systems, Inc.), Fukuda Denshi Co., Ltd., Schiller AG, Mortara Instrument Inc., BPL Medical Technologies, and Lepu Medical Technology(Beijing) Co.,Ltd |
Heart beat irregularity detection devices are used for detection for heartbeats, and refers to the techniques used by doctors to determine the type and origin of abnormal cardiac rhythms.
Arrhythmias, which are deviations from the heart's regular rhythm or speed, can be divided into different groups based on where in the heart they occur. The left or right atrium, one of the two upper chambers of the heart, might have an atrial or supraventricular arrhythmia. The lower chambers of the heart, the ventricles, are the genesis of ventricular arrhythmias, which can impair the heart's capacity to pump blood to the body.
The mainly used device by the physicians within the global market is electrocardiogram (ECG).
According to Future Market Insights, the global market has huge growth potential due to the growing incidence of cardiovascular diseases.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for heart beat irregularity detection devices expanded at a CAGR of 5.4% during the historic period (2017 to 2022) and reached a market value of US$ 12.8 Million in 2022.
Arrhythmia refers to an irregular heartbeat. In case of arrhythmia, the heart may beat faster or slower than it would in the absence of one. The heart may beat erratically due to a variety of issues, and the cause will decide the best course of treatment.
Symptoms of cardiac arrhythmia include palpitation, hammering in the chest, dizziness, weakness, weariness, chest tightness, weakening of the heart muscle, and poor ejection fraction.
Some of the reasons of cardiac arrhythmia include coronary artery disease, high blood pressure, irritable tissue in the heart, valve abnormalities, healing process after surgery, changes in heart muscle, and injuries following a heart attack.
The global market is predicted to expand 1.5X its current size by the end of 2033.
| Market Statistics | Details |
|---|---|
| Jan - Jun (H1), 2021 (A) | 3.89% |
| Jul - Dec (H2), 2021 (A) | 4.88% |
| Jan - Jun (H1),2022 Projected (P) | 3.83% |
| Jan - Jun (H1),2022 Outlook (O) | 4.02% |
| Jul - Dec (H2), 2022 Outlook (O) | 4.98% |
| Jul - Dec (H2), 2022 Projected (P) | 4.70% |
| Jan - Jun (H1), 2023 Projected (P) | 4.06% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 20↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 13↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 27↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 9↑ |
Principal Consultant
Medical professionals and consumers are concerned about security weaknesses in medical devices, notably cardiac implanted electronic devices (CIED). Up to 750,000 Medtronic PLC cardiac devices contained a severe cybersecurity flaw in 2019, allowing an attacker with insider knowledge to injure the patient by modifying the programming of an advanced implantable defibrillator.
A shortage of qualified specialists, as well as the detrimental impact of some heart beat irregularity detection devices on patients, are some of the reasons impeding the growth of the heart beat irregularity detection market.
According to the World Health Organization, cardiovascular disease (CVD) is the leading cause of mortality globally, and approximately 30 Million individuals experience a heart attack or stroke each year. Family history, age, cigarette smoking, hypertension, high cholesterol, obesity, physical inactivity, diabetes, poor diets, and excessive alcohol consumption are just a few risk factors that might lead to CVD.
According to the American Heart Association, more than 130 Million Americans are expected to have CVD by 2035, accounting for over half of all adult Americans. People with severe CVD need to be regularly monitored to prevent abrupt heart failure since they are more likely to experience cardiac arrhythmias including tachycardia and bradycardia. The majority of CVDs can be prevented through pre-monitoring and pre-diagnosis. This is the primary factor stimulating the market for heart beat irregularity detection devices.
Recent advancements in HIPPA-compliant technology have enabled safe data transfer without interruptions during the monitoring time for heartbeat detection devices. Innovative new technologies also offer efficient substitutes for conventional Holter monitors that generate alarms for patients with high cardiac arrhythmia risk.
Because of this, the long-term paired with uninterrupted cardiac rhythm control capabilities of such devices may have a beneficial impact on market growth. Through a collaboration with Access Physician, Cuero Regional Hospital, introduced TeleCardiology services in January 2019. These factors are also anticipated to spur the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United States |
|---|---|
| Market Share (2023) | 29.5% |
| Market Share (2033) | 28.9% |
| BPS Analysis | -59 |
| Country | China |
|---|---|
| Market Share (2023) | 9.5% |
| Market Share (2033) | 10.2% |
| BPS Analysis | 69 |
| Country | Germany |
|---|---|
| Market Share (2023) | 6.8% |
| Market Share (2033) | 7.3% |
| BPS Analysis | 43 |
| Country | France |
|---|---|
| Market Share (2023) | 5.2% |
| Market Share (2033) | 5.0% |
| BPS Analysis | -20 |
| Country | India |
|---|---|
| Market Share (2023) | 4.6% |
| Market Share (2033) | 4.4% |
| BPS Analysis | -18 |
The United States is set to hold a share of around 29.5% of the global market in 2023. The regional growth is attributed to expanding use of cutting-edge cardiovascular technologies and sophisticated healthcare infrastructure.
By 2030, 12.1 Million Americans are expected to suffer atrial fibrillation, according to the Centers for Disease Control and Prevention (CDC). Such figures suggest that the need for heart beat irregularity detection devices is anticipated to expand, consequently contributing to the market's growth, as AFib is the most prevalent kind of cardiac arrhythmia detected among the patient population in the region.
Germany is set to hold a share of 5.2% of the global market in 2023.
The prevalence of cardiovascular disorders is rising, and there is a growing preference for minimally invasive procedures, which is actively affecting the market's expansion.
According to estimates from the German Heart Surgery Report 2021, 36,714 heart valve treatments and 19,490 procedures involving pacemakers and ICDs was done as part of the estimated 161,261 cardiac procedures in Germany in 2021. The demand for heart beat irregularity detection devices in Germany is rising as a result of the large number of cardiac surgeries.
China is set to hold 9.5% revenue share within the global market space in 2023.
The market for heart beat irregularity detection devices is driven by an increase in the prevalence of cardiovascular diseases, an ageing population that is more prone to coronary heart disease, technological advancements in cardiac monitoring devices that reduce the risk of infection, and increased device effectiveness.
One of the primary underlying causes of heart disease and lung cancer is smoking. The WHO estimates that smoking contributes to over 1 Million cardiovascular deaths in the Asia-Pacific area each year. Smoking causes more than 1 in 5 cardiovascular diseases, including heart attack and stroke.
Electrocardiogram devices are expected to hold a market share of 42.0% in 2023. An ECG records the electrical activity of the heart. It is a painless routine test that is used to quickly discover cardiac abnormalities and keep track of the heart's health; this benefit is likely to fuel the segment's expansion.
The device may be used during chest pain, rapid pulse, heart palpitations, weakness, fatigue, and other, to determine irregular heart rhythms also known as arrhythmias, previous heart attacks, how the pacemaker are working, is blocked or narrowed arteries in the heart are causing chest pain or a heart attack.
Technological developments in this devices such as portable EKG is also the reason behind segment growth. This portable device is small in size and weight, and is simple to operate that transmits data in real time phones and computers.
As per the applications the market has been segmented into tachycardia, bradycardia, premature contractions, and others, in which tachycardia is expected to hold a market share of 30.1% in 2023. Tachycardia is further segmented into atrial tachycardia and ventricular tachycardia.
In the upcoming years, it is anticipated that there will be a rise in the use of technologically improved devices for disease monitoring.
A thorough course of treatment is necessary for atrial tachycardia, a kind of supraventricular tachycardia, to improve outcomes. Devices that can detect abnormal heartbeats are very important for improving disease diagnosis and therapy. Consequently, it is anticipated that the increasing risk of tachycardia would increase the market growth.
The hospitals and clinic segment is set to hold 36.8% revenue share in 2023 globally. The significant share of this market is attributed to factors like the rising incidence of CVD, the rising number of diagnostic hospital patient visits, and the rising number of cardiac implant surgeries. According to the American Heart Association, arrhythmias affect more than 4 Million people and cause close to half a Million fatalities annually in the United States.
Technology and medicine are now integrated, and the twenty-first century has witnessed the introduction of previously bulky, single-function gadgets to a transportable, portable, and multipurpose platform. There has been a shift in the last ten years towards handheld ECG tracking systems that are more compact and portable. Within a hospital or clinic or between patient rooms on a cart for mobility, these gadgets can be easily accommodated, this benefits of the devices with increasing adoption is anticipated to boost the segment growth.
In order to compete in the global heart beat irregularity detection device market, well-known manufacturers who produce and provide cardiac arrhythmia monitoring devices concentrate on releasing improved products. In order to increase their consumer base, these companies are now engaging in strategic alliances with important players in neighboring countries and local companies.
A novel strategy used by manufacturers to increase patient and healthcare professional interest in the device that detects heartbeat is the incorporation of digital software.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the heart beat irregularity detection device space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Distribution Channel, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
Alive Cor and GE Healthcare are the key manufacturers in the global market.
The market is forecast to register a CAGR of 4.5% through 2033.
From 2018 to 2022, the market registered a CAGR of 5.4%.
Rising early detection of optimal care is driving global market opportunities.
The global market size is to reach US$ 20.7 billion by 2033.
1. Executive Summary | Heart Beat Irregularity Detection Device Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Product Adoption Analysis
4.3. Regulatory Scenario
4.4. Reimbursement Landscape
4.5. PESTEL Analysis
4.6. Porter’s Analysis
4.7. Value Chain Analysis
4.8. Technology Assessment
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare GDP Growth Outlook
5.1.3. Global Cardiac Arrhythmia Monitoring Devices Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growing Cases of Cardiac Disorders
5.2.2. Product Launch Activities
5.2.3. Technology Assessment
5.2.4. Reimbursement Scenario
5.2.5. Increased Adoption of Low Cost ECG Services
5.2.6. Growing Adoption of Continuous Patient Monitoring
5.2.7. Rising Disposable Income
5.2.8. Strategic Collaborations among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Device
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2022 Market Scenario
7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2017 to 2022
7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Device
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2032 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Device
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Device, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Device, 2023 to 2033
10.3.1. Holter Monitor
10.3.2. Event Recorder
10.3.3. Mobile Cardiac Telemetry
10.3.4. Implantable Cardiac Monitor
10.3.5. Electrocardiogram
10.3.6. Others
10.4. Market Attractiveness Analysis By Device
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Application, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Tachycardia
11.3.1.1. Atrial Tachycardia
11.3.1.2. Ventricular Tachycardia
11.3.2. Bradycardia
11.3.3. Premature Contraction
11.3.4. Others
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End-User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By End-User, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
12.3.1. Hospitals and Clinics
12.3.2. Diagnostic Centers
12.3.3. Ambulatory Surgical Centers
12.3.4. Homecare Settings
12.3.5. Others
12.4. Market Attractiveness Analysis By End-User
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022
13.3. Current Market and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. The USA
14.4.1.2. Canada
14.4.2. By Device
14.4.3. By Application
14.4.4. By End-User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Device
14.5.3. By Application
14.5.4. By End-User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
14.9.1. USA Market Analysis
14.9.1.1. Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Device
14.9.1.2.2. By Application
14.9.1.2.3. By End-User
14.9.2. Canada Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Device
14.9.2.2.2. By Application
14.9.2.2.3. By End-User
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. Mexico
15.4.1.2. Brazil
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Device
15.4.3. By Application
15.4.4. By End-User
15.5. By End-User Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Device
15.5.3. By Application
15.5.4. By End-User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. Mexico Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Device
15.9.1.2.2. By Application
15.9.1.2.3. By End-User
15.9.2. Brazil Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Device
15.9.2.2.2. By Application
15.9.2.2.3. By End-User
15.9.3. Argentina Market Analysis
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Device
15.9.3.2.2. By Application
15.9.3.2.3. By End-User
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
16.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. United Kingdom
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Device
16.4.3. By Application
16.4.4. By End-User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Device
16.5.3. By Application
16.5.4. By End-User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. Germany Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Device
16.9.1.2.2. By Application
16.9.1.2.3. By End-User
16.9.2. Italy Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Device
16.9.2.2.2. By Application
16.9.2.2.3. By End-User
16.9.3. France Market Analysis
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Device
16.9.3.2.2. By Application
16.9.3.2.3. By End-User
16.9.4. United Kingdom Market Analysis
16.9.4.1. Introduction
16.9.4.2. Market Analysis and Forecast by Market Taxonomy
16.9.4.2.1. By Device
16.9.4.2.2. By Application
16.9.4.2.3. By End-User
16.9.5. Spain Market Analysis
16.9.5.1. Introduction
16.9.5.2. Market Analysis and Forecast by Market Taxonomy
16.9.5.2.1. By Device
16.9.5.2.2. By Application
16.9.5.2.3. By End-User
16.9.6. BENELUX Market Analysis
16.9.6.1. Introduction
16.9.6.2. Market Analysis and Forecast by Market Taxonomy
16.9.6.2.1. By Device
16.9.6.2.2. By Application
16.9.6.2.3. By End-User
16.9.7. Russia Market Analysis
16.9.7.1. Introduction
16.9.7.2. Market Analysis and Forecast by Market Taxonomy
16.9.7.2.1. By Device
16.9.7.2.2. By Application
16.9.7.2.3. By End-User
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
17.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Indonesia
17.4.1.3. Malaysia
17.4.1.4. Thailand
17.4.1.5. Rest of South Asia
17.4.2. By Device
17.4.3. By Application
17.4.4. By End-User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Device
17.5.3. By Application
17.5.4. By End-User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. India Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Device
17.9.1.2.2. By Application
17.9.1.2.3. By End-User
17.9.2. Indonesia Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Device
17.9.2.2.2. By Application
17.9.2.2.3. By End-User
17.9.3. Malaysia Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Device
17.9.3.2.2. By Application
17.9.3.2.3. By End-User
17.9.4. Thailand Market Analysis
17.9.4.1. Introduction
17.9.4.2. Market Analysis and Forecast by Market Taxonomy
17.9.4.2.1. By Device
17.9.4.2.2. By Application
17.9.4.2.3. By End-User
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
18.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Device
18.4.3. By Application
18.4.4. By End-User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Device
18.5.3. By Application
18.5.4. By End-User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country Level Analysis & Forecast
18.9.1. China Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Device
18.9.1.2.2. By Application
18.9.1.2.3. By End-User
18.9.2. Japan Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Device
18.9.2.2.2. By Application
18.9.2.2.3. By End-User
18.9.3. South Korea Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Device
18.9.3.2.2. By Application
18.9.3.2.3. By End-User
19. Oceania Market 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
19.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Device
19.4.3. By Application
19.4.4. By End-User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Device
19.5.3. By Application
19.5.4. By End-User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
19.9. Country Level Analysis & Forecast
19.9.1. Australia Market Analysis
19.9.1.1. Introduction
19.9.1.2. Market Analysis and Forecast by Market Taxonomy
19.9.1.2.1. By Device
19.9.1.2.2. By Application
19.9.1.2.3. By End-User
19.9.2. New Zealand Market Analysis
19.9.2.1. Introduction
19.9.2.2. Market Analysis and Forecast by Market Taxonomy
19.9.2.2.1. By Device
19.9.2.2.2. By Application
19.9.2.2.3. By End-User
20. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
20.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Türkiye
20.4.1.3. South Africa
20.4.1.4. North Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Device
20.4.3. By Application
20.4.4. By End-User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Device
20.5.3. By Application
20.5.4. By End-User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. GCC Countries Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Device
20.9.1.2.2. By Application
20.9.1.2.3. By End-User
20.9.2. Türkiye Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Device
20.9.2.2.2. By Application
20.9.2.2.3. By End-User
20.9.3. South Africa Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Device
20.9.3.2.2. By Application
20.9.3.2.3. By End-User
20.9.4. North Africa Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Device
20.9.4.2.2. By Application
20.9.4.2.3. By End-User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Alive Cor
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. SWOT Analysis
22.3.1.5. Key Financials
22.3.1.6. Strategy Overview
22.3.2. Applied Cardiac Systems
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. SWOT Analysis
22.3.2.5. Key Financials
22.3.2.6. Strategy Overview
22.3.3. Biotronik
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. SWOT Analysis
22.3.3.5. Key Financials
22.3.3.6. Strategy Overview
22.3.4. Biotricity
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. SWOT Analysis
22.3.4.5. Key Financials
22.3.4.6. Strategy Overview
22.3.5. GE Healthcare
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. SWOT Analysis
22.3.5.5. Key Financials
22.3.5.6. Strategy Overview
22.3.6. iRhythm Technologies
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. SWOT Analysis
22.3.6.5. Key Financials
22.3.6.6. Strategy Overview
22.3.7. Koninklijke Philips N.V.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. SWOT Analysis
22.3.7.5. Key Financials
22.3.7.6. Strategy Overview
22.3.8. Medtronic plc.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. SWOT Analysis
22.3.8.5. Key Financials
22.3.8.6. Strategy Overview
22.3.9. Nihon Kohden Corporation
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. SWOT Analysis
22.3.9.5. Key Financials
22.3.9.6. Strategy Overview
22.3.10. St. Jude Medical (Abbott Laboratories)
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. SWOT Analysis
22.3.10.5. Key Financials
22.3.10.6. Strategy Overview
22.3.11. Welch Allyn (Hillrom Services, Inc.)
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. SWOT Analysis
22.3.11.5. Key Financials
22.3.11.6. Strategy Overview
22.3.12. NUUBO Smart Solutions Technologies, SL
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. SWOT Analysis
22.3.12.5. Key Financials
22.3.12.6. Strategy Overview
22.3.13. Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. SWOT Analysis
22.3.13.5. Key Financials
22.3.13.6. Strategy Overview
22.3.14. Fukuda Denshi Co., Ltd.
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Sales Footprint
22.3.14.4. SWOT Analysis
22.3.14.5. Key Financials
22.3.14.6. Strategy Overview
22.3.15. Schiller AG
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Sales Footprint
22.3.15.4. SWOT Analysis
22.3.15.5. Key Financials
22.3.15.6. Strategy Overview
22.3.16. Mortara Instrument Inc.
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Sales Footprint
22.3.16.4. SWOT Analysis
22.3.16.5. Key Financials
22.3.16.6. Strategy Overview
22.3.17. BPL Medical Technologies
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Sales Footprint
22.3.17.4. SWOT Analysis
22.3.17.5. Key Financials
22.3.17.6. Strategy Overview
22.3.18. Lepu Medical Technology(Beijing)Co.,Ltd
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Sales Footprint
22.3.18.4. SWOT Analysis
22.3.18.5. Key Financials
22.3.18.6. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Heart Beat Irregularity Detection Device Market
